Article Text

Download PDFPDF
Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET
  1. Lidia Kasprzaka,
  2. Serge Noletb,
  3. Louis Gabouryb,
  4. Carles Paviac,
  5. Carles Villabonad,
  6. Francisca Rivera-Fillate,
  7. Josep Oriolae,
  8. William D Foulkesa,f
  1. aProgram in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada, bDépartement de Pathologie, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada, cServei d'Hormonologia, (IDIBAPS), Hospital Clínic, Barcelona, Spain, dSecció de Endocrinologia, Hospital Universitari de Sant Joan de Deu, Barcelona, Spain, eServei d'Endocrinologia, CSU Bellvitge, Hospital Principes de España, Barcelona, Spain, fDepartment of Medicine, Research Institute of the McGill University Health Centre, Montreal General Hospital, Room L10-116, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada
  1. Dr Foulkes,WILLIAM.FOULKES{at}MCGILL.CA

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor—Germline mutations in theRET proto-oncogene are associated with multiple endocrine neoplasia (MEN) type 2A, 2B, and familial medullary thyroid carcinoma (FMTC). MEN 2A is characterised primarily by medullary thyroid carcinoma (MTC), parathyroid hyperplasia, and phaeochromocytoma. MEN 2B has additional stigmata including a marfanoid habitus, mucosal neuromas, and corneal nerve thickening. In FMTC, the only lesion present is MTC. Although characteristic of MEN 2B, prominent corneal nerves have been noted in subjects with MEN 2A.

Case reports

We have studied a family presenting with MTC and corneal nerve thickening (CNT), but no evidence of MEN 2 related disease outside the thyroid gland (fig 1). The proband (III.1) was found to have prominent corneal nerves on routine ophthalmological examination in his late 30s. No further action was taken and he presented with a palpable thyroid mass at the age of 53.

Figure 1

A truncated pedigree of the family is shown. Filled symbols indicate affected subjects. The letters below the symbols refer to the site of cancer, the numbers following the abbreviations indicate age at diagnosis. MTC, medullary thyroid cancer; PSU, primary site unknown; d, age at death; CNT, corneal nerve thickening.

MEN 2B was suspected and he was referred for laboratory screening tests for MTC and phaeochromocytoma. Serum calcitonin was raised at 4090 ng/l (normal range <60 ng/l). Serum calcium and phosphorus were normal. Twenty four hour urinary total catecholamine, metanephrine, and vanillylmandelic acid levels were within normal limits. A thoracic and abdominal CT scan performed before surgery was normal and scanning of the neck confirmed the presence of the right thyroid mass. The patient underwent a total thyroidectomy and pathological examination indicated bilateral MTC with extension beyond the capsule. His endocrinologist referred him for a genetic evaluation with a diagnosis of MEN 2B. However, other than CNT, he and his relatives …

View Full Text